Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
148 Cards in this Set
- Front
- Back
what are myeloid tissues?
|
bone marrow and cells derived from it
RBCs, PLTs, granulocytes, monocytes |
|
what are lymphoid tissues?
|
thymus, LNs, spleen
|
|
which stages in hematopoesis are capable of self-renewal?
|
the first (stem cell) stage only
|
|
what stimulates the differentiation of hematopoetic stem cells?
|
stem cell factor (SCF aka cKIT ligand)
IL-6 FLT3 ligand |
|
what stimulates the differentiation myeloid progenitor cells into CFU-GM?
|
GM-CSF
|
|
what stimulates the differentiation of myeloid progenitor cells to CFU-b/Mg and BFU-E?
|
Thrombopoietin, IL-11
|
|
what mediates the differentiation of CFU-GM?
|
G-CSF --> CFU-G (myeloblast --> neutrophil)
M-CSF --> CFU-M (monoblast --> monocyte) |
|
what stimulates production of eosinophils?
from what progenitor are they derived? |
IL-5
common myeloid progenitor --> CFU-eo --> eosinophiloblast |
|
where in bone marrow are normal megakaryocytes located?
|
next to sinusoids, extend cytoplasmic processes that bud off into blood as plts
|
|
where in bone marrow are RBC precursors located?
|
surround macrophages (nurse cells) that provide iron for Hb synthesis
|
|
what generalized changes in bone marrow are seen in disease states?
|
Increased fat: aplastic anemia
Decreased fat: hematopoietic tumors, dzs w/ compensatory hyperplasia, and leukemias Local marrow fibrosis: metastatic cancers and granulomatous dzs |
|
MCC of agranulocytosis?
|
drug toxicity
|
|
Drugs implicated in agranulocytosis?
|
aminopyrine
chloramphenicol sulfonamides chlorpromazine thiouracil phenylbutazone |
|
which drugs cause neutropenia thru a toxic effect on granulocytic precursors in marrow?
|
chlorpromazine and thenothiazines
|
|
what is the most common sign of agranulocytosis?
|
ulcerating necrotizing lesions of the gingiva and oral cavity
|
|
MCC of neutrophilic leukocytosis?
|
infection
|
|
which growth factor induces neutrophilia?
what are causes of its release? |
G-CSF
acute bact infxn (esp pyogenic bact); sterile inflammation (eg tissue necrosis) |
|
causes of eosinophilia?
|
allergy (hay fever, asthma)
skin diseases parasitic infxns drug rxns some malignancies (hodgkin & non-hodgkin lymphomas) collagen vascular dzs and vasculitides atheroembolic dz |
|
causes of basophilia?
|
(Rare) myeloproliferative dzs (eg CML)
|
|
causes of monocytosis?
|
chronic infxn, bact endocarditis, rickettsiosis, malaria
collagen vascular dzs (eg SLE) inflamm bowel dzs (eg UC) |
|
causes of lymphocytosis?
|
comes w/ monocytosis in chronic immunological stimulation disorders (tb, brucellosis)
viral infxns B. pertussis infxn |
|
difference between neutropenia from peripheral destruction and neutropenia from destruction of granulocytic precursors?
|
bone marrow is hypercellular
bone marrow is hypocellular |
|
morphologic neutrophil chgs in sepsis or severe inflammatory disorders?
|
toxic granules (abnormally coarse, dark granules)
Dohle bodies (blue cytoplasmic patches of dilated ER) cytoplasmic vacuoles |
|
MCC of acute cervical lymphadenitis?
|
infections of teeth or tonsils
|
|
MCC of acute axillary or inguinal lymphadenitis?
|
infections in extremities
|
|
MCC of acute generalized lymphadenopathy?
|
systemic viral infxns (esp in children), bacteremia
|
|
when does scarring of LNs occur?
|
after suppurative rxns to pyogenic organisms
|
|
activation of humoral immune response results in what type of LN rxn?
|
follicular hyperplasia
|
|
activation of T cell mediated immune response results in what type of LN rxn?
|
Paracortical hyperplasia
|
|
How to differentiate between follicular hyperplasia and follicular lymphoma?
|
Hyperplasia:
-maintains LN architecture -has marked variation in shape/size of nodules -has frequent mitotic figures, phagocytic macrophages, and recognizable light and dark zones |
|
MCCs of paracortical lymphoid hyperplasia?
|
immunologic rxns induced by drugs (esp phenytoin)
acute viral infxn (esp EBV) |
|
LN changes seen especially in LNs draining cancers such as carcinoma of the breast?
|
sinus histiocytosis (aka reticular hyperplasia):
increase in # and size of cells that line lymphatic sinusoids |
|
what are histiocytoses?
|
uncommon proliferative lesions of macrophages and dendritic cells, esp Langerhans cells
|
|
from what normal mechanism do most lymphoid neoplasms derive?
|
B cell class switching and somatic hypermutations to generate Ab diversity; most commonly translocations
|
|
t(9,22) is associated with what disease(s)?
|
ALL, AML, CML
|
|
what inherited genetic factors predispose to WBC neoplasias?
|
Bloom syndrome, Fanconi anemia, ataxia telangiectasia = Acute leukemias
+21, NF-1 = childhood leukemias |
|
Which viruses predispose to WBC neoplasias?
|
HTLV-1 = adult T cell leukemia/lymphoma
EBV = Burkitt lymphoma, Hodgkin lymphoma, other B cell lymphomas in setting of T-cell immunodeficiency and NK-cell lymphomas KSHV = Kaposi sarcoma |
|
what environmental agent is associated with gastric B-cell lymphomas?
|
H. pylori infection
|
|
chronic immune stimulation in what disease is associated with intestinal T-cell lymphomas?
|
gluten-sensitive enteropathy
|
|
term used for neoplasms with widespread BM involvement and usually peripheral blood
|
leukemia
|
|
term used for WBC proliferations that arise as discrete tissue masses
|
lymphoma
|
|
2/3 of NHLs and almost all Hodgkin's lymphomas present with what symptom?
|
enlarged, nontender LNs
|
|
which plasma cell neoplasm often presents as pain d/t pathologic fractures?
|
multiple myeloma
|
|
which WBC neoplasms cause symptoms through the secretion of circulating factors?
|
plasma cell tumors (secretion of antibodies or fragments)
Hodgkin lymphoma (fever d/t release of inflammatory cytokines) |
|
most common origin of lymphoid neoplasm?
|
B-cell origin
|
|
MCC of cancer in children?
|
ALL
|
|
which subset of ALL presents as childhood leukemia?
|
B-ALL
|
|
which lymphoid neoplasm presents in adolescent males as thymic lymphomas (mediastinal mass)?
|
T-ALL
|
|
characteristic cells of this neoplasm are positive for TdT, PAS and acid phosphatase
|
ALL
|
|
lymphoblasts express CD19 and karyotype shows hyperdiploidy and t(12,21)?
|
B ALL
|
|
lymphoblasts often express CD1a and gain-of-fxn mutations in NOTCH1?
|
T ALL
|
|
clinical features of ALLs?
|
- abrupt, stormy onset
- sxs related to BMS (fatigue, fever, bleeding) - mass effect (bone pain, organomegaly, lymphadenopathy, testicular enlargement) - CNS (HA, vomiting, nerve palsies) |
|
which WBC neoplasm causes compression of large vessels and airways in the mediastinum?
|
T-ALL
|
|
what factors are associated with poorer prognosis in ALL?
|
- age < 2 or > 10
- blast counts > 100,000 - t(9,22) |
|
what factors are associated with better prognosis in ALL?
|
- age 2-10
- low WBC - hyperploidy - trisomy 4,7,10 - t(12,21) |
|
which drug is used in t(9,22)+ ALLs and inhibits BCR-ABL kinase?
|
Imatinib (Gleevec)
|
|
ALL responsiveness to aggressive chemo (including CNS prophylaxis)?
|
CR in 90% of children, 2/3 cured
|
|
MCC of leukemia of adults in Western world?
|
CLL
|
|
difference between CLL and SLL?
|
degree of peripheral blood lymphocytosis
|
|
WBC neoplasm in which abnml cells gather in LNs in proliferation centers; PBS contains smudge cells?
|
CLL/SLL
|
|
Neoplastic cells are positive for CD19, CD20, CD23, and CD5;
deletions in 13q, 11q, 17p, trisomy 12q? |
CLL/SLL
|
|
poor prognosis in CLL/SLL is associated with what progression of disease?
|
prolymphocytic transformation (worsening cytopenias, inc splenomegaly, inc # prolymphocytes)
Richter syndrome - transformation to diffuse large B-cell lymphoma (rapidly enlarging mass in LN or spleen) |
|
tumor that arises from germinal center B cells and is strongly assoc'd w/ translocations involving BCL2 [t(14,18)]?
|
Follicular lymphoma
|
|
LN findings in follicular lymphoma?
|
centrocytes - small, cleaved cells
centroblasts - larger cells w/ open chromatin, several nucleoli, modest amts of cytoplasm |
|
what are the results of t(14,18) mutation?
|
BCL2 and Ig heavy chain loci switch, BCL2 is overexpressed, promotes survival of follicular lymphoma cells by blocking bax channel
|
|
MCC of NHL in United States?
|
follicular lymphoma
|
|
response of follicular lymphomas to chemo/rad?
|
survival is not improved by aggressive therapy
|
|
mature B-cell tumors that express CD19, CD20 and sometimes translocation of BCL6; typically present at extranodal sites (GI, skin, bone, brain); aggressive, rapidly proliferating; may respond to therapy?
|
Diffuse large B-cell lymphoma
|
|
what are special subsets of diffuse large B-cell lymphoma?
|
- may occur in setting of severe T-cell immunodeficiency; cells are usually infected with EBV
- may present as malignant pleural or ascitic effusion; mostly in advanced HIV or elderly; always infected with KSHV/HHV-8 |
|
neoplasm with medium sized lymphocytes, "starry-sky" appearance, c-MYC t(8,14)?
|
Burkitt lymphoma
|
|
B-cell neoplasm assoc'd with EBV, presents in maxilla or mandible, involves kidneys, ovaries, adrenal glands?
|
African (endemic) Burkitt lymphoma
|
|
B-cell neoplasm with high incidence in AIDS, presents as mass involving ileocecum or peritoneum?
|
American (sporadic) Burkitt lymphoma
|
|
neoplasm of older adults presenting with hypercalcemia, bone pain, pathologic fxrs; inc gamma proteins, Bence-Jones proteins, and "punched-out" lesions of skull?
|
Multiple myeloma (plasma cell myeloma)
|
|
what causes lytic bone lesions in multiple myeloma?
|
inc osteoclast activating factor (OAF, IL-6)
MIP1a induces expression of RANKL which activates osteoclasts Modulators of Wnt pathway inhibit osteoblasts |
|
Disorder in which protein casts in DCT and collecting ducts are surrounded by multinucleated giant cells?
|
myeloma kidney
|
|
MCC of death in multiple myeloma?
|
infection (inc susceptibility d/t dec production of serum Ig's)
|
|
most common plasma cell dyscrasia?
|
monoclonal gammopathy of uncertain significance (MGUS)
|
|
MCC of elevated serum M protein level (< 3gm/dL) in asymptomatic older patient?
|
MGUS
|
|
B-cell neoplasm that infiltrates many organs, has M spike (IgM), but no hypercalcemia, and no lytic bone lesions present?
|
Lymphoplasmacytic lymphoma
|
|
what are Russell bodies and Dutcher bodies?
|
Russell bodies - cytoplasmic immunoglobulin
Dutcher bodies - intranuclear immunoglobulin characteristic of lymphoplasmacytic lymphoma |
|
hyperviscosity syndrome, associated with lymphoplasmacytic lymphoma, causes what complications?
|
vascular dilations and retinal hemorrhages --> visual problems
neuro sxs (HA, confusion) abnml globulins cause bleeding and cryoglobulinemia (precipitate at low temp and cause Raynaud phenomenon) |
|
lymphoid neoplasm of older males consisting of small, cleaved lymphocytes, but no proliferation centers, no large centroblasts; t(11,14), high levels of cyclin D, CD5+, CD23-?
|
Mantle cell lymphoma
|
|
B-cell tumor that commonly occurs at sites of chronic immune or inflammatory reactions?
|
marginal zone lymphomas (MALTomas)
|
|
Disease of middle-aged white males, may cause "dry tap" BM aspirate, presents with red beefy splenomegaly d/t infiltration of red pulp; stains positive for tartrate-resistant acid phosphatase (TRAP)
|
Hairy cell leukemia
|
|
neoplasm of CD4+ T-cells in adults infected with HTLV-1, esp. in Japan, W Africa, Caribbean; presents w/ skin lesions, hypercalcemia, enlarged LN, liver, and spleen; cloverleaf nuclei?
|
Adult T-cell Leukemia/Lymphoma (ATLL)
|
|
tumor of CD4+ T-cells that causes generalized pruritic erythematous rash (w/o hypercalcemia); abnml cells have cerebriform nuclei?
|
Mycosis fungoides/Sezary syndrome
|
|
difference btwn MF and Sezary syndrome?
|
skin lesions of sezary syndrome rarely become tumors
sezary cells (cerebriform nuclei) are found in peripheral blood in sezary syndrome, only found in epidermis/dermis in MF |
|
rare neoplasm of CD8 T-cells, lymphocytes have abundant cytoplasm with coarse azurophilic granules?
|
Large granular lymphocytic leukemia
|
|
neoplasm presenting as descructive midline mass involving nasopharynx, skin, or testes; highly associated with EBV?
|
extranodal NK/T-cell lymphoma
|
|
how is HD different from NHL?
|
- presents with fever
- spread is to contiguous (adjacent) nodal groups - characterization based on inflammatory response instead of malignant cell - no leukemic state - extranodal spread uncommon |
|
neoplastic cell of this disease has "owl eye" bilobed nucleus w/ central nucleoli surrounded by clear space
|
Hodgkin lymphoma
(Reed-Sternberg cells) |
|
HL variant that has L&H "popcorn" cells and are negative for CD15 and CD30, but positive for B-cell markers CD20 and BCL6?
|
lymphocyte predominance type
|
|
most common type of HL; has lacunar variant Reed-Sternberg cells that are positive for PAX5, CD15 and CD30; nuclear deposition of collagen in bands?
|
Nodular sclerosis type
|
|
type of HL with infiltrate of T-cells, eosinophils, plasma cells, benign macrophages with Reed-Sternberg cells; RS cells often infected with EBV?
|
Mixed-cellularity type
|
|
type of HL with few lymphocytes, many RS cells?
|
lymphocyte depleted type
|
|
stereotyped progression of spread of HL?
|
nodal dz --> splenic dz --> hepatic dz --> marrow and other tissues
|
|
clinical presentations of HL?
|
usually painless lymphadenopathy
disseminated dz, mixed-cellularity or LD types may have B-cell symptoms: waxing/waning fever, wt loss, night sweats |
|
population at risk for AML?
|
adults
|
|
dx of AML is based on what?
|
>= 20% myeloid blasts in bone marrow
|
|
many myeloblasts on PBS, auer rods, peroxidase+ azurophilic cytoplasmic granules - Dx?
|
AML
|
|
auer rods are especially pronounced in what neoplasia (specific translocation)?
|
t(15,17) - acute promyelocytic leukemia
|
|
treatment of M3 subtype AML?
|
all-trans retinoic acid (ATRA) - induces differentiation of myeloblasts
|
|
difference between acute leukemias and chronic leukemias?
|
mostly blasts (acute), more mature cells (chronic)
children or elderly (acute), midlife (chronic) short and drastic (acute), longer, less devastating (chronic) |
|
karyotypic abnormalities associated with AML?
|
de novo: t(8;21), inv(16), t(15;17)
following MDS or exposure to DNA-damaging agents: del or monosomies of 5 & 7 after tx w/ topoisomerase II inhibitors: MLL chromosome (11q23) |
|
disorder associated with t(8;14)?
|
burkitt lymphoma (c-myc activation)
|
|
disorder associated with t(14;18)?
|
follicular lymphomas (bcl-2 activation)
|
|
disorder associated with t(15;17)?
|
M3 type AML
|
|
disorder associated with t(11;22)?
|
Ewing's sarcoma
|
|
disorder associated with t(11;14)?
|
Mantle cell lymphoma
|
|
most common presentation of AML?
|
sxs related to anemia, neutropenia, TCpenia (fatigue, fever, spontaneous mucosal and cutaneous bleeding)
|
|
what factors contribute to bleeding diathesis in AML?
|
thrombocytopenia
procoagulants and fibrinolytic factors released by leukemic cells (esp in t[15;17]) |
|
which types of AML are high-risk?
|
those that follow MDS or genotoxic therapy or that occur in elderly
|
|
primary and t-MDS are associated with what karyotypic abnormalities?
|
monosomy 5 and 7
del 5q, 7q, 20q trisomy 8 |
|
most common finding in MDS?
|
dysplastic differentiation affecting all three myeloid lineages (erythroid, granulocytic and megakaryocytic)
|
|
morphological changes seen in MDS?
|
erythroid: ringed sideroblasts, megaloblastoid maturation, nuclear budding abnormalities
granulocytic; neutrophils with dec or abnml/toxic granules, pseudo-Pelger-Huet cells Megakaryocytic: pawn ball meg.cytes |
|
what are pseudo-Pelger-Huet cells?
|
neutrophils with only two lobes (seen in MDS)
|
|
primary MDS affects what age group?
|
> 60 y
|
|
what are the chronic myeloproliferative disorders?
|
- CML
- polycythemia vera - essential thrombocytosis - myelofibrosis w/ myleoid metaplasia |
|
what features are common to all MPDs?
|
- neoplastic stem cells home in to secondary hematopoietic organs, esp spleen, leading to splenomegaly
- terminal spent phase: marrow fibrosis and peripheral cytopenias - progression to acute leukemia |
|
what is the biomechanical change that occurs in CML?
|
BCR gene (22) fuses with ABL gene (9) and synthesizes a constitutively active tyr-kinase, stimulating proliferation and survival of marrow progenitors
does not interfere with differentiation --> increase in mature cells in blood, esp granulocytes and plts |
|
what lab finding helps differentiate between CML and other leukemoid reactions?
|
absence of leukocyte alk phos in CML
|
|
cell counts in CML - RBCs, WBCs, Plts?
|
dec RBCs
inc WBCs inc Plts |
|
pharm tx of CML?
|
Imatinib (anti-bcr-abl antibody)
|
|
disease characterized by increased marrow production of RBCs, granulocytes, and plts?
|
polycythemia vera
|
|
mutation implicated in polycythemia vera?
|
activating point mutations in tyr-kinase JAK2
|
|
difference between polycythemia vera and secondary absoulte polycythemia?
|
PCV = low EPO
secondary polycythemias = high EPO |
|
symptoms of PCV?
|
plethora and cyanosis (d/t stagnation and deox of blood in peripheral vessels),
HA, dizziness, HTN, GI sxs, DVT, MI, stroke |
|
why do some pts w/ PCV have HCT within normal range?
|
chronic bleeding leads to iron deficiency which suppresses erythropoiesis
|
|
extended survival with PCV leads to what?
|
"spent phase" clinically resembling myelofibrosis
|
|
pathogenesis of essential thrombocytosis?
|
same JAK2 point mutation as in PCV - receptor tyr-kinase activation makes progenitors thrombopoeitin-independent
|
|
major manifestations of ET?
|
thrombosis and hemorrhage
DVT, portal and hepatic vein thrombosis, MI, erythromelalgia |
|
what is erythromelalgia?
|
throbbing and burning of hands and feet caused by occlusion of small arterioles by plt aggregates
seen in ET and PCV |
|
pathogenesis of primary myelofibrosis?
|
inappropriate release of PDGF and TGF-beta from neoplastic megakaryocytes (fibrogenic factors)
|
|
in what disease are large platelets and dacryocytes found?
|
myelofibrosis
(dacryocytes = teardrop shaped RBCs damaged during birthing process in fibrotic marrow) |
|
cause of splenomegaly in primary myelofibrosis?
|
circulating hematopoeitic stem cells home to secondary hematopoietic organs esp spleen, liver, LNs
|
|
secondary disorder that can complicate the picture of MPDs?
|
hyperuricemia and gout (from high cell turnover rate)
|
|
infant develops cutaneous seborrheic-like eruption on chest, back, and scalp; also has hepatosplenomegaly, lymphadenopathy, pulmonary lesions. Dx?
|
Letterer-Siwe disease
(Multifocal multisystem Langerhans cell histiocytosis) |
|
pathogenesis of primary myelofibrosis?
|
inappropriate release of PDGF and TGF-beta from neoplastic megakaryocytes (fibrogenic factors)
|
|
in what disease are large platelets and dacryocytes found?
|
myelofibrosis
(dacryocytes = teardrop shaped RBCs damaged during birthing process in fibrotic marrow) |
|
cause of splenomegaly in primary myelofibrosis?
|
circulating hematopoeitic stem cells home to secondary hematopoietic organs esp spleen, liver, LNs
|
|
secondary disorder that can complicate the picture of MPDs?
|
hyperuricemia and gout (from high cell turnover rate)
|
|
infant develops cutaneous seborrheic-like eruption on chest, back, and scalp; also has hepatosplenomegaly, lymphadenopathy, pulmonary lesions. Dx?
|
Letterer-Siwe disease
(Multifocal multisystem Langerhans cell histiocytosis) |
|
What is the Hand-Schuller-Christian triad?
|
calvarial bone defects, diabetes insipidus, and exophthalmos
(multifocal unisystem Langerhans cell histiocytosis that involves the posterior pituitary stalk) |
|
causes of congestive splenomegaly?
|
venous obstruction d/t intrahepatic disorders (esp. cirrhosis) that slow portal venous drainage or extrahepatic disorders that impinge upon portal or plenic veins (pylephlebitis, portal vein thrombosis)
|
|
MCC of splenic infarctions?
|
emboli arising from the heart
|
|
MCC of thymic hypoplasia?
|
DiGeorge syndrome
|
|
MCC of thymic hyperplasia?
|
myasthenia gravis
(also seen in other AI dz: Graves, SLE, scleroderma, RA) |
|
difference between invasive thymoma and thymic carcinoma?
|
invasive thymoma is cytologically benign but locally invasive
thymic carcinoma is invasive, somtimes accompanied by metastases, usually squamous cell carcinoma |